2,871 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Acquired by Argus Investors Counsel Inc.

Argus Investors Counsel Inc. bought a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 2,871 shares of the company’s stock, valued at approximately $224,000.

Several other hedge funds have also recently added to or reduced their stakes in GEHC. Cherry Creek Investment Advisors Inc. boosted its stake in shares of GE HealthCare Technologies by 0.3% during the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company’s stock valued at $2,920,000 after buying an additional 114 shares during the period. Independence Bank of Kentucky lifted its stake in shares of GE HealthCare Technologies by 6.0% in the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company’s stock valued at $158,000 after buying an additional 114 shares during the period. Tandem Capital Management Corp ADV lifted its stake in shares of GE HealthCare Technologies by 0.4% in the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock valued at $2,205,000 after buying an additional 118 shares during the period. Custom Index Systems LLC lifted its stake in shares of GE HealthCare Technologies by 4.4% in the fourth quarter. Custom Index Systems LLC now owns 2,843 shares of the company’s stock valued at $222,000 after buying an additional 120 shares during the period. Finally, Greenleaf Trust raised its position in GE HealthCare Technologies by 1.7% in the third quarter. Greenleaf Trust now owns 7,619 shares of the company’s stock worth $715,000 after purchasing an additional 124 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $87.17 on Thursday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.55. The firm’s fifty day moving average price is $83.14 and its 200-day moving average price is $85.15. The stock has a market cap of $39.83 billion, a P/E ratio of 23.95, a price-to-earnings-growth ratio of 2.92 and a beta of 1.14.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.85%.

Wall Street Analyst Weigh In

GEHC has been the topic of several research analyst reports. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company lifted their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $96.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.